TrustCore Financial Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

TrustCore Financial Services’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-150	Closed	-$4K	–	1154
2022 Q2	$4K	Hold	150	–	–	﹤0.01%	884
2022 Q1	$5K	Sell	150 -77	-34%	-$2.67K	﹤0.01%	862
2021 Q4	$10K	Hold	227	–	–	﹤0.01%	709
2021 Q3	$10K	Hold	227	–	–	﹤0.01%	768
2021 Q2	$11K	Hold	227	–	–	﹤0.01%	723
2021 Q1	$11K	Hold	227	–	–	﹤0.01%	681
2020 Q4	$12K	Buy	+227	New	+$10.8K	﹤0.01%	650

Other funds holding SBIO

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.28B AUM 22.9% 1-Year Est. Return

ASB Consultores Aventura, Florida $66.1M AUM 28.66% 1-Year Est. Return

TrustCore Financial Services's SBIO Position: Q3 2022 in Review

TrustCore Financial Services sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2022, closing a stake of 150 shares — an estimated $4K sold.

TrustCore Financial Services first reported a position in SBIO in Q4 2020 and held it in 7 quarters. The position peaked at $12K in Q4 2020. 44 funds tracked by Wall St. Rank hold SBIO as of Q3 2022.

TrustCore Financial Services reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2022 after selling out during the quarter.
TrustCore Financial Services sold 150 ALPS Medical Breakthroughs ETF shares in Q3 2022, an estimated $4K.
TrustCore Financial Services first reported a position in ALPS Medical Breakthroughs ETF in Q4 2020 and held it in 7 quarters.
TrustCore Financial Services's ALPS Medical Breakthroughs ETF position peaked at $12K in Q4 2020.
44 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2022.

Based on TrustCore Financial Services's 13F filing for Q3 2022, filed 3 Nov 2022.